Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review)

  • Authors:
    • Ying Fu
    • Sha‑Sha Yuan
    • Li‑Jie Zhang
    • Zhi‑Li Ji
    • Xiao‑Jiang Quan
  • View Affiliations / Copyright

    Affiliations: Key Laboratory of Diabetes Prevention and Research, Endocrinology Center, Lu He Hospital, Capital Medical University, Beijing 101149, P.R. China
    Copyright: © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2595-2605
    |
    Published online on: July 8, 2020
       https://doi.org/10.3892/ol.2020.11833
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Establishing the link between cellular processes and oncogenesis may aid the elucidation of targeted and effective therapies against tumor cell proliferation and metastasis. Previous studies have investigated the mechanisms involved in maintaining the balance between cell proliferation, differentiation and migration. There is increased interest in determining the conditions that allow cancer stem cells to differentiate as well as the identification of molecules that may serve as novel drug targets. Furthermore, the study of various genes, including transcription factors, which serve a crucial role in cellular processes, may present a promising direction for future therapy. The present review described the role of the transcription factor atonal bHLH transcription factor 1 (ATOH1) in signaling pathways in tumorigenesis, particularly in cerebellar tumor medulloblastoma and colorectal cancer, where ATOH1 serves as an oncogene or tumor suppressor, respectively. Additionally, the present review summarized the associated therapeutic interventions for these two types of tumors and discussed novel clinical targets and approaches.
View Figures

Figure 1

Figure 2

View References

1 

Kompella P and Vasquez KM: Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability. Mol Carcinog. 58:1531–1550. 2019. View Article : Google Scholar : PubMed/NCBI

2 

Murata M: Inflammation and cancer. Environ Health Prev Med. 23:502018. View Article : Google Scholar : PubMed/NCBI

3 

Axelrad JE, Lichtiger S and Yajnik V: Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 22:4794–4801. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Raskov H, Soby JH, Troelsen J, Bojesen RD and Gogenur I: Driver gene mutations and epigenetics in colorectal Cancer. Ann Surg. 271:75–85. 2020. View Article : Google Scholar : PubMed/NCBI

5 

Todd R and Wong DT: Oncogenes. Anticancer Res. 19:4729–4746. 1999.PubMed/NCBI

6 

Bos JL: Ras oncogenes in human cancer: A review. Cancer Res. 49:4682–4689. 1989.PubMed/NCBI

7 

Felsher DW and Bishop JM: Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell. 4:199–207. 1999. View Article : Google Scholar : PubMed/NCBI

8 

Cargnello M and Roux PP: Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Hisada M, Garber JE, Fung CY, Fraumeni JF and Li FP: Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 90:606–611. 1998. View Article : Google Scholar : PubMed/NCBI

10 

National Cancer Institute, . Genetic Testing for Hereditary Cancer Syndromes. June 21–, 2016

11 

National Cancer Institute, . Physician Data Query (PDQ). Cancer Genetics Overview. 2016. June 21–2016

12 

National Cancer Institute, . Physician Data Query (PDQ). Genetics of Breast and Ovarian Cancer. 2016. June 21–2016

13 

Chang-Claude J: Inherited genetic susceptibility to breast cancer. IARC Sci Publ. 154:177–190. 2001.PubMed/NCBI

14 

National Cancer Institute, . Physician Data Query (PDQ). Genetics of Colorectal Cancer. 2016. June 21–2016

15 

Akazawa C, Ishibashi M, Shimizu C, Nakanishi S and Kageyama R: A mammalian helix-loop-helix factor structurally related to the product of Drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system. J Biol Chem. 270:8730–8738. 1995. View Article : Google Scholar : PubMed/NCBI

16 

Cai T and Groves AK: The role of atonal factors in mechanosensory cell specification and function. Mol Neurobiol. 52:1315–1329. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Chonko KT, Jahan I, Stone J, Wright MC, Fujiyama T, Hoshino M, Fritzsch B and Maricich SM: Atoh1 directs hair cell differentiation and survival in the late embryonic mouse inner ear. Dev Biolo. 381:401–410. 2013. View Article : Google Scholar

18 

Ben-Arie N, Bellen HJ, Armstrong DL, McCall AE, Gordadze PR, Guo Q, Matzuk MM and Zoghbi HY: Math1 is essential for genesis of cerebellar granule neurons. Nature. 390:169–172. 1997. View Article : Google Scholar : PubMed/NCBI

19 

Machold R and Fishell G: Math1 is expressed in temporally discrete pools of cerebellar rhombic-lip neural progenitors. Neuron. 48:17–24. 2005. View Article : Google Scholar : PubMed/NCBI

20 

Rose MF, Ren J, Ahmad KA, Chao HT, Klisch TJ, Flora A, Greer JJ and Zoghbi HY: Math1 is essential for the development of hindbrain neurons critical for perinatal breathing. Neuron. 64:341–354. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Ayrault O, Zhao H, Zindy F, Qu C, Sherr CJ and Roussel MF: Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. Cancer Res. 70:5618–5627. 2010. View Article : Google Scholar : PubMed/NCBI

22 

Flora A, Klisch TJ, Schuster G and Zoghbi HY: Deletion of Atoh1 disrupts Sonic Hedgehog signaling in the developing cerebellum and prevents medulloblastoma. Science. 326:1424–1427. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, Bourboulas M, Schüller U, Machold R, Fishell G, Rowitch DH, et al: Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell. 14:135–145. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Leow CC, Romero MS, Ross S, Polakis P and Gao WQ: Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res. 64:6050–6057. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Yang Q, Bermingham NA, Finegold MJ and Zoghbi HY: Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 294:2155–2158. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Bossuyt W, Kazanjian A, De Geest N, Van Kelst S, De Hertogh G, Geboes K, Boivin GP, Luciani J, Fuks F, Chuah M, et al: Atonal homolog 1 is a tumor suppressor gene. PLoS Biol. 7:e392009. View Article : Google Scholar : PubMed/NCBI

27 

Peignon G, Durand A, Cacheux W, Ayrault O, Terris B, Laurent-Puig P, Shroyer NF, Van Seuningen I, Honjo T, Perret C, et al: Complex interplay between beta-catenin signalling and Notch effectors in intestinal tumorigenesis. Gut. 60:166–176. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Huang C, Chan JA and Schuurmans C: Proneural bHLH genes in development and disease. Curr Top Dev Biol. 110:75–127. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Leonard JH, Cook AL, Van Gele M, Boyle GM, Inglis KJ, Speleman F and Sturm RA: Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma. Int J Cancer. 101:103–110. 2002. View Article : Google Scholar : PubMed/NCBI

30 

Xu HT, Xie XM, Li QC, Liu SL, Dai SD, Liu Y and Wang EH: Atonal homolog 1 expression in lung cancer correlates with inhibitors of the Wnt pathway as well as the differentiation and primary tumor stage. APMIS. 121:111–119. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Hou K, Jiang H, Karim MR, Zhong C, Xu Z, Liu L, Guan M, Shao J and Huang X: A Critical E-box in Barhl1 3′ enhancer is essential for auditory hair cell differentiation. Cells. 8(pii): E4582019. View Article : Google Scholar : PubMed/NCBI

32 

Scheffer D, Sage C, Corey DP and Pingault V: Gene expression profiling identifies Hes6 as a transcriptional target of ATOH1 in cochlear hair cells. FEBS Lett. 581:4651–4666. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Jarman AP, Grau Y, Jan LY and Jan YN: Atonal is a proneural gene that directs chordotonal organ formation in the Drosophila peripheral nervous system. Cell. 73:1307–1321. 1993. View Article : Google Scholar : PubMed/NCBI

34 

Jarman AP, Grell EH, Ackerman L, Jan LY and Jan YN: Atonal is the proneural gene for Drosophila photoreceptors. Nature. 369:398–400. 1994. View Article : Google Scholar : PubMed/NCBI

35 

Mulvaney J and Dabdoub A: Atoh1, an essential transcription factor in neurogenesis and intestinal and inner ear development: Function, regulation, and context dependency. J Assoc Res Otolaryngol. 13:281–293. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Weinberger S, Topping MP, Yan J, Claeys A, Geest N, Ozbay D, Hassan T, He X, Albert JT, Hassan BA and Ramaekers A: Evolutionary changes in transcription factor coding sequence quantitatively alter sensory organ development and function. Elife. 6(pii): e264022017. View Article : Google Scholar : PubMed/NCBI

37 

Quan XJ, Denayer T, Yan J, Jafar-Nejad H, Philippi A, Lichtarge O, Vleminckx K and Hassan BA: Evolution of neural precursor selection: Functional divergence of proneural proteins. Development. 131:1679–1689. 2004. View Article : Google Scholar : PubMed/NCBI

38 

Aerts S, Quan XJ, Claeys A, Naval Sanchez M, Tate P, Yan J and Hassan BA: Robust target gene discovery through transcriptome perturbations and genome-wide enhancer predictions in Drosophila uncovers a regulatory basis for sensory specification. PLoS Biol. 8:e10004352010. View Article : Google Scholar : PubMed/NCBI

39 

Klisch TJ, Xi Y, Flora A, Wang L, Li W and Zoghbi HY: In vivo Atoh1 targetome reveals how a proneural transcription factor regulates cerebellar development. Proc Natl Acad Sci USA. 108:3288–3293. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Gazit R, Krizhanovsky V and Ben-Arie N: Math1 controls cerebellar granule cell differentiation by regulating multiple components of the Notch signaling pathway. Development. 131:903–913. 2004. View Article : Google Scholar : PubMed/NCBI

41 

VanDussen KL and Samuelson LC: Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fate. Dev Biol. 346:215–223. 2010. View Article : Google Scholar : PubMed/NCBI

42 

Peignon G, Durand A, Cacheux W, Ayrault O, Terris B, Laurent-Puig P, Shroyer NF, Van Seuningen I, Honjo T, Perret C and Romagnolo B: Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis. Gut. 60:166–176. 2011. View Article : Google Scholar : PubMed/NCBI

43 

Flora A, Garcia JJ, Thaller C and Zoghbi HY: The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc Natl Acad Sci USA. 104:15382–15387. 2007. View Article : Google Scholar : PubMed/NCBI

44 

Lee KJ, Dietrich P and Jessell TM: Genetic ablation reveals that the roof plate is essential for dorsal interneuron specification. Nature. 403:734–740. 2000. View Article : Google Scholar : PubMed/NCBI

45 

Zhao H, Ayrault O, Zindy F, Kim JH and Roussel MF: Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes Dev. 22:722–727. 2008. View Article : Google Scholar : PubMed/NCBI

46 

Hu X, Huang J, Feng L, Fukudome S, Hamajima Y and Lin J: Sonic hedgehog (SHH) promotes the differentiation of mouse cochlear neural progenitors via the Math1-Brn3.1 signaling pathway in vitro. J Neurosci Res. 88:927–935. 2010. View Article : Google Scholar : PubMed/NCBI

47 

Moll I, Roessler M, Brandner JM, Eispert AC, Houdek P and Moll R: Human Merkel cells-aspects of cell biology, distribution and functions. Eur J Cell Biol. 84:259–271. 2005. View Article : Google Scholar : PubMed/NCBI

48 

Wellnitz SA, Lesniak DR, Gerling GJ and Lumpkin EA: The regularity of sustained firing reveals two populations of slowly adapting touch receptors in mouse hairy skin. J Neurophysiol. 103:3378–3388. 2010. View Article : Google Scholar : PubMed/NCBI

49 

Ben-Arie N, Hassan BA, Bermingham NA, Malicki DM, Armstrong D, Matzuk M, Bellen HJ and Zoghbi HY: Functional conservation of atonal and Math1 in the CNS and PNS. Development. 127:1039–1048. 2000.PubMed/NCBI

50 

Haeberle H, Fujiwara M, Chuang J, Medina MM, Panditrao MV, Bechstedt S, Howard J and Lumpkin EA: Molecular profiling reveals synaptic release machinery in Merkel cells. Proc Natl Acad Sci USA. 101:14503–14508. 2004. View Article : Google Scholar : PubMed/NCBI

51 

Wright MC, Reed-Geaghan EG, Bolock AM, Fujiyama T, Hoshino M and Maricich SM: Unipotent, ATOH1+ progenitors maintain the Merkel cell population in embryonic and adult mice. J Cell Biol. 208:367–379. 2015. View Article : Google Scholar : PubMed/NCBI

52 

Maricich SM, Wellnitz SA, Nelson AM, Lesniak DR, Gerling GJ, Lumpkin EA and Zoghbi HY: Merkel cells are essential for light-touch responses. Science. 324:1580–1582. 2009. View Article : Google Scholar : PubMed/NCBI

53 

Bardot ES, Valdes VJ, Zhang J, Perdigoto CN, Nicolis S, Hearn SA, Silva JM and Ezhkova E: Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cells. EMBO J. 32:1990–2000. 2013. View Article : Google Scholar : PubMed/NCBI

54 

Coggshall K, Tello TL, North JP and Yu SS: Merkel cell carcinoma: An update and review: Pathogenesis, diagnosis, and staging. J Am Acad Dermatol. 78:433–442. 2018. View Article : Google Scholar : PubMed/NCBI

55 

Tello TL, Coggshall K, Yom SS and Yu SS: Merkel cell carcinoma: An update and review: Current and future therapy. J Am Acad Dermatol. 78:445–454. 2018. View Article : Google Scholar : PubMed/NCBI

56 

Liu W, MacDonald M and You J: Merkel cell polyomavirus infection and Merkel cell carcinoma. Curr Opin Virol. 20:20–27. 2016. View Article : Google Scholar : PubMed/NCBI

57 

Schadendorf D, Lebbé C, Zur Hausen A, Avril MF, Hariharan S, Bharmal M and Becker JC: Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 71:53–69. 2017. View Article : Google Scholar : PubMed/NCBI

58 

Gambichler T, Mohtezebsade S, Wieland U, Silling S, Hoh AK, Dreissigacker M, Schaller J, Schulze HJ, Oellig F, Kreuter A, et al: Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma. J Cancer Res Clin Oncol. 143:43–49. 2017. View Article : Google Scholar : PubMed/NCBI

59 

Briggs KJ, Corcoran-Schwartz IM, Zhang W, Harcke T, Devereux WL, Baylin SB, Eberhart CG and Watkins DN: Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma. Genes Dev. 22:770–785. 2008. View Article : Google Scholar : PubMed/NCBI

60 

Schüller U, Heine VM, Mao J, Kho AT, Dillon AK, Han YG, Huillard E, Sun T, Ligon AH, Qian Y, et al: Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell. 14:123–134. 2008. View Article : Google Scholar : PubMed/NCBI

61 

Shroyer NF, Helmrath MA, Wang VY, Antalffy B, Henning SJ and Zoghbi HY: Intestine-specific ablation of mouse atonal homolog 1 (Math1) reveals a role in cellular homeostasis. Gastroenterology. 132:2478–2488. 2007. View Article : Google Scholar : PubMed/NCBI

62 

Peignon G, Durand A, Cacheux W, Ayrault O, Terris B, Laurent-Puig P, Shroyer NF, Van Seuningen I, Honjo T, Perret C, et al: Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis. Gut. 60:166–176. 2011. View Article : Google Scholar : PubMed/NCBI

63 

Westerman BA, Breuer RH, Poutsma A, Chhatta A, Noorduyn LA, Koolen MG, Postmus PE, Blankenstein MA and Oudejans CB: Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors. Int J Biol Markers. 22:114–123. 2007. View Article : Google Scholar : PubMed/NCBI

64 

Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA. 98:13790–13795. 2001. View Article : Google Scholar : PubMed/NCBI

65 

Hiroshima K, Iyoda A, Shibuya K, Toyozaki T, Haga Y, Fujisawa T and Ohwada H: Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Ann Thorac Surg. 73:1732–1735. 2002. View Article : Google Scholar : PubMed/NCBI

66 

Berendsen HH, de Leij L, Poppema S, Postmus PE, Boes A, Sluiter HJ and The H: Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol. 7:1614–1620. 1989. View Article : Google Scholar : PubMed/NCBI

67 

Ben-Arie N, McCall AE, Berkman S, Eichele G, Bellen HJ and Zoghbi HY: Evolutionary conservation of sequence and expression of the bHLH protein Atonal suggests a conserved role in neurogenesis. Hum Mol Genet. 5:1207–1216. 1996. View Article : Google Scholar : PubMed/NCBI

68 

Bermingham NA, Hassan BA, Wang VY, Fernandez M, Banfi S, Bellen HJ, Fritzsch B and Zoghbi HY: Proprioceptor pathway development is dependent on Math1. Neuron. 30:411–422. 2001. View Article : Google Scholar : PubMed/NCBI

69 

Iulianella A, Wingate RJ, Moens CB and Capaldo E: The generation of granule cells during the development and evolution of the cerebellum. Dev Dyn. 248:506–513. 2019. View Article : Google Scholar : PubMed/NCBI

70 

Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, et al: Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol. 24:1924–1931. 2006. View Article : Google Scholar : PubMed/NCBI

71 

Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, et al: Subtypes of medulloblastoma have distinct developmental origins. Nature. 468:1095–1099. 2010. View Article : Google Scholar : PubMed/NCBI

72 

Gilbertson RJ and Ellison DW: The origins of medulloblastoma subtypes. Ann Rev Pathol. 3:341–365. 2008. View Article : Google Scholar

73 

Lee Y, Miller HL, Jensen P, Hernan R, Connelly M, Wetmore C, Zindy F, Roussel MF, Curran T, Gilbertson RJ and McKinnon PJ: A molecular fingerprint for medulloblastoma. Cancer Res. 63:5428–5437. 2003.PubMed/NCBI

74 

Vaillant C, Valdivieso P, Nuciforo S, Kool M, Schwarzentruber-Schauerte A, Mereau H, Cabuy E, Lobrinus JA, Pfister S, Zuniga A, et al: Serpine2/PN-1 is required for proliferative expansion of pre-neoplastic lesions and malignant progression to medulloblastoma. PLoS One. 10:e01248702015. View Article : Google Scholar : PubMed/NCBI

75 

Blaess S, Corrales JD and Joyner AL: Sonic hedgehog regulates Gli activator and repressor functions with spatial and temporal precision in the mid/hindbrain region Development 133. 1799–1809. 2006.PubMed/NCBI

76 

Briggs KJ, Eberhart CG and Watkins DN: Just say no to ATOH: How HIC1 methylation might predispose medulloblastoma to lineage addiction. Cancer Res. 68:8654–8666. 2008. View Article : Google Scholar : PubMed/NCBI

77 

Klisch TJ, Vainshtein A, Patel AJ and Zoghbi HY: Jak2-mediated phosphorylation of ATOH1 is critical for medulloblastoma growth. Elife. 6(pii): e311812017. View Article : Google Scholar : PubMed/NCBI

78 

Salsano E, Pollo B, Eoli M, Giordana MT and Finocchiaro G: Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types. Neurosci Lett. 370:180–185. 2004. View Article : Google Scholar : PubMed/NCBI

79 

Zhao H, Ayrault O, Zindy F, Kim JH and Roussel MF: Post-transcriptional down-regulation of ATOH1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes Dev. 22:722–727. 2008. View Article : Google Scholar : PubMed/NCBI

80 

Garraway LA, Weir BA, Zhao X, Widlund H, Beroukhim R, Berger A, Rimm D, Rubin MA, Fisher DE, Meyerson ML and Sellers WR: ‘Lineage addiction’ in human cancer: Lessons from integrated genomics. Cold Spring Harb Symp Quant Biol. 70:25–34. 2005. View Article : Google Scholar : PubMed/NCBI

81 

Zakrzewska M, Gresner SM, Zakrzewski K, Zalewska-Szewczyk B and Liberski PP: Novel gene expression model for outcome prediction in paediatric medulloblastoma. J Mol Neurosci. 51:371–379. 2013. View Article : Google Scholar : PubMed/NCBI

82 

Lum L and Beachy PA: The Hedgehog response network: Sensors, switches, and routers. Science. 304:1755–1759. 2004. View Article : Google Scholar : PubMed/NCBI

83 

Katoh Y and Katoh M: Integrative genomic analyses on GLI1: Positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. Int J Oncol. 35:187–192. 2009. View Article : Google Scholar : PubMed/NCBI

84 

Browd SR, Kenney AM, Gottfried ON, Yoon JW, Walterhouse D, Pedone CA and Fults DW: N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Cancer Res. 66:2666–2672. 2006. View Article : Google Scholar : PubMed/NCBI

85 

Eberhart CG: Medulloblastoma in mice lacking p53 and PARP: All roads lead to Gli. Am J Pathol. 162:7–10. 2003. View Article : Google Scholar : PubMed/NCBI

86 

Chiba S, Takeshita K, Imai Y, Kumano K, Kurokawa M, Masuda S, Shimizu K, Nakamura S, Ruddle FH and Hirai H: Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells. Proc Natl Acad Sci USA. 100:15577–15582. 2003. View Article : Google Scholar : PubMed/NCBI

87 

Harris SE, Guo D, Harris MA, Krishnaswamy A and Lichtler A: Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: Role of Dlx2 and Dlx5 transcription factors. Front Biosci. 8:s1249–s1265. 2003. View Article : Google Scholar : PubMed/NCBI

88 

Katoh Y and Katoh M: Comparative genomics on HHIP family orthologs. Int J Mol Med. 17:391–395. 2006.PubMed/NCBI

89 

Kamaid A, Neves J and Giraldez F: Id gene regulation and function in the prosensory domains of the chicken inner ear: A link between Bmp signaling and ATOH1. J Neurosci. 30:11426–11434. 2010. View Article : Google Scholar : PubMed/NCBI

90 

Angley C, Kumar M, Dinsio KJ, Hall AK and Siegel RE: Signaling by bone morphogenetic proteins and Smad1 modulates the postnatal differentiation of cerebellar cells. J Neurosci. 23:260–268. 2003. View Article : Google Scholar : PubMed/NCBI

91 

Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 4:P32003. View Article : Google Scholar : PubMed/NCBI

92 

Killeen MT and Sybingco SS: Netrin, Slit and Wnt receptors allow axons to choose the axis of migration. Dev Biol. 323:143–151. 2008. View Article : Google Scholar : PubMed/NCBI

93 

Zou YR, Kottmann AH, Kuroda M, Taniuchi I and Littman DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:595–599. 1998. View Article : Google Scholar : PubMed/NCBI

94 

Adamson DC, Shi Q, Wortham M, Northcott PA, Di C, Duncan CG, Li J, McLendon RE, Bigner DD, Taylor MD and Yan H: OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. Cancer Res. 70:181–191. 2010. View Article : Google Scholar : PubMed/NCBI

95 

Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM and Beachy PA: Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 297:1559–1561. 2002. View Article : Google Scholar : PubMed/NCBI

96 

Romer JT, Kimura H, Magdaleno S, Sasai K, Fuller C, Baines H, Connelly M, Stewart CF, Gould S, Rubin LL and Curran T: Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(−/-) mice. Cancer Cell. 6:229–240. 2004. View Article : Google Scholar : PubMed/NCBI

97 

Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, Hatton BA, Russell TL, Ellenbogen RG, Bernstein ID, Beachy PA and Olson JM: The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res. 64:7794–7800. 2004. View Article : Google Scholar : PubMed/NCBI

98 

Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, et al: Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet. 41:465–472. 2009. View Article : Google Scholar : PubMed/NCBI

99 

Stanton BZ and Peng LF: Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst. 6:44–54. 2010. View Article : Google Scholar : PubMed/NCBI

100 

Vlckova K, Reda J, Ondrusova L, Krayem M, Ghanem G and Vachtenheim J: GLI inhibitor GANT61 kills melanoma cells and acts in synergy with obatoclax. Int J Oncol. 49:953–960. 2016. View Article : Google Scholar : PubMed/NCBI

101 

Northcott PA, Rutka JT and Taylor MD: Genomics of medulloblastoma: From Giemsa-banding to next-generation sequencing in 20 years. Neurosurg Focus. 28:E62010. View Article : Google Scholar : PubMed/NCBI

102 

Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP, Strand AD, Tapscott SJ and Olson JM: BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med. 9:1033–1038. 2003. View Article : Google Scholar : PubMed/NCBI

103 

Kazanjian A, Noah T, Brown D, Burkart J and Shroyer NF: Atonal homolog 1 is required for growth and differentiation effects of notch/gamma-secretase inhibitors on normal and cancerous intestinal epithelial cells. Gastroenterology. 139:918–928. 2010. View Article : Google Scholar : PubMed/NCBI

104 

Kim TH and Shivdasani RA: Genetic evidence that intestinal Notch functions vary regionally and operate through a common mechanism of Math1 repression. J Biol Chem. 286:11427–11433. 2011. View Article : Google Scholar : PubMed/NCBI

105 

Noah TK and Shroyer NF: Notch in the intestine: Regulation of homeostasis and pathogenesis. Annu Rev Physiol. 75:263–288. 2013. View Article : Google Scholar : PubMed/NCBI

106 

Van Keymeulen A, Mascre G, Youseff KK, Harel I, Michaux C, De Geest N, Szpalski C, Achouri Y, Bloch W, Hassan BA and Blanpain C: Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol. 187:91–100. 2009. View Article : Google Scholar : PubMed/NCBI

107 

Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ and Clevers H: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 449:1003–1307. 2007. View Article : Google Scholar : PubMed/NCBI

108 

Reedijk M, Odorcic S, Zhang H, Chetty R, Tennert C, Dickson BC, Lockwood G, Gallinger S and Egan SE: Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol. 33:1223–1229. 2008.PubMed/NCBI

109 

van Es JH, de Geest N, van de Born M, Clevers H and Hassan BA: Intestinal stem cells lacking the Math1 tumour suppressor are refractory to Notch inhibitors. Nat Commun. 1:182010. View Article : Google Scholar : PubMed/NCBI

110 

Guilmeau S, Flandez M, Mariadason JM and Augenlicht LH: Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: Implications for targeting Notch signaling. Oncogene. 29:992–1002. 2010. View Article : Google Scholar : PubMed/NCBI

111 

Sikandar SS, Pate KT, Anderson S, Dizon D, Edwards RA, Waterman ML and Lipkin SM: NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res. 70:1469–1478. 2010. View Article : Google Scholar : PubMed/NCBI

112 

Fre S, Pallavi SK, Huyghe M, Lae M, Janssen KP, Robine S, Artavanis-Tsakonas S and Louvard D: Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci USA. 106:6309–6314. 2009. View Article : Google Scholar : PubMed/NCBI

113 

van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, Robine S, Winton DJ, Radtke F and Clevers H: Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 435:959–963. 2005. View Article : Google Scholar : PubMed/NCBI

114 

Zhu DH, Niu BL, Du HM, Ren K, Sun JM and Gong JP: Hath1 inhibits proliferation of colon cancer cells probably through up-regulating expression of Muc2 and p27 and down-regulating expression of cyclin D1. Asian Pac J Cancer Prev. 13:6349–6355. 2012. View Article : Google Scholar : PubMed/NCBI

115 

Tsuchiya K, Nakamura T, Okamoto R, Kanai T and Watanabe M: Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer. Gastroenterology. 132:208–220. 2007. View Article : Google Scholar : PubMed/NCBI

116 

Park ET, Oh HK, Gum JR Jr, Crawley SC, Kakar S, Engel J, Leow CC, Gao WQ and Kim YS: HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin Cancer Res. 12:5403–5410. 2006. View Article : Google Scholar : PubMed/NCBI

117 

Aragaki M, Tsuchiya K, Okamoto R, Yoshioka S, Nakamura T, Sakamoto N, Kanai T and Watanabe M: Proteasomal degradation of ATOH1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer. Biochem Biophys Res Commun. 368:923–929. 2008. View Article : Google Scholar : PubMed/NCBI

118 

Polakis P: Wnt signaling and cancer. Genes Dev. 14:1837–1851. 2000.PubMed/NCBI

119 

Polakis P: The oncogenic activation of beta-catenin. Curr Opin Genet Dev. 9:15–21. 1999. View Article : Google Scholar : PubMed/NCBI

120 

Quan XJ, Yuan L, Tiberi L, Claeys A, De Geest N, Yan J, van der Kant R, Xie WR, Klisch TJ, Shymkowitz J, et al: Post-translational control of the temporal dynamics of transcription factor activity regulates neurogenesis. Cell. 164:460–475. 2016. View Article : Google Scholar : PubMed/NCBI

121 

Tomic G, Morrissey E, Kozar S, Ben-Moshe S, Hoyle A, Azzarelli R, Kemp R, Chilamakuri CSR, Itzkovitz S, Philpott A and Winton DJ: Phospho-regulation of ATOH1 is required for plasticity of secretory progenitors and tissue regeneration. Cell Stem Cell. 23:436–43.e7. 2018. View Article : Google Scholar : PubMed/NCBI

122 

Yang X, Zhang L, Song X, He W, Zhang D, Lu Q, Wu J, Wu C and Jiang J: MicroRNA-613 promotes colon cancer cell proliferation, invasion and migration by targeting ATOH1. Biochem Biophys Res Commun. 504:827–833. 2018. View Article : Google Scholar : PubMed/NCBI

123 

Ponz de Leon M and Di Gregorio C: Pathology of colorectal cancer. Digestive and liver disease: Official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 33:372–388. 2001. View Article : Google Scholar : PubMed/NCBI

124 

Hooper LV and Macpherson AJ: Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 10:159–169. 2010. View Article : Google Scholar : PubMed/NCBI

125 

Hollingsworth MA and Swanson BJ: Mucins in cancer: Protection and control of the cell surface. Nat Rev Cancer. 4:45–60. 2004. View Article : Google Scholar : PubMed/NCBI

126 

Sheng XZ, Xu GJ, Tang XQ and Zhan WB: Monoclonal antibodies recognizing mucus immunoglobulin and surface immunoglobulin-positive cells of flounder (Paralichthys olivaceus). Vet Immunol Immunopathol. 145:143–150. 2012. View Article : Google Scholar : PubMed/NCBI

127 

Corfield AP, Carroll D, Myerscough N and Probert CS: Mucins in the gastrointestinal tract in health and disease. Front Biosci. 6:D1321–D1357. 2001. View Article : Google Scholar : PubMed/NCBI

128 

Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K and Augenlicht L: Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 295:1726–1729. 2002. View Article : Google Scholar : PubMed/NCBI

129 

Byrd JC and Bresalier RS: Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23:77–99. 2004. View Article : Google Scholar : PubMed/NCBI

130 

Noah TK, Kazanjian A, Whitsett J and Shroyer NF: SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells. Exp Cell Res. 316:452–265. 2010. View Article : Google Scholar : PubMed/NCBI

131 

Lo YH, Chung E, Li Z, Wan YW, Mahe MM, Chen MS, Noah TK, Bell KN, Yalamanchili HK, Klisch TJ, et al: Transcriptional regulation by ATOH1 and its Target SPDEF in the intestine. Cell Mol Gastroenterol Hepatol. 3:51–71. 2017. View Article : Google Scholar : PubMed/NCBI

132 

Noah TK, Lo YH, Price A, Chen G, King E, Washington MK, Aronow BJ and Shroyer NF: SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity. Gastroenterology. 144:1012–1023.e6. 2013. View Article : Google Scholar : PubMed/NCBI

133 

Riccio O, van Gijn ME, Bezdek AC, Pellegrinet L, van Es JH, Zimber-Strobl U, Strobl LJ, Honjo T, Clevers H and Radtke F: Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. EMBO Rep. 9:377–383. 2008. View Article : Google Scholar : PubMed/NCBI

134 

Souaze F, Bou-Hanna C, Kandel C, Leclair F, Devalliere J, Charreau B, Bézieau S, Mosnier JF and Laboisse CL: Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: A translational study. PLoS One. 8:e559042013. View Article : Google Scholar : PubMed/NCBI

135 

Aragaki M, Tsuchiya K, Okamoto R, Yoshioka S, Nakamura T, Sakamoto N, Kanai T and Watanabe M: Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer. Biochem Biophys Res Commun. 368:923–929. 2008. View Article : Google Scholar : PubMed/NCBI

136 

Cohen Y, Chetrit A, Cohen Y, Sirota P and Modan B: Cancer morbidity in psychiatric patients: Influence of lithium carbonate treatment. Med Oncol. 15:32–36. 1998. View Article : Google Scholar : PubMed/NCBI

137 

Gould TD, Gray NA and Manji HK: Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice. Pharmacol Res. 48:49–53. 2003.PubMed/NCBI

138 

Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, Kawakami K and Minamoto T: Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci. 98:1388–1393. 2007. View Article : Google Scholar : PubMed/NCBI

139 

Tan J, Zhuang L, Leong HS, Iyer NG, Liu ET and Yu Q: Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res. 65:9012–9020. 2005. View Article : Google Scholar : PubMed/NCBI

140 

Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, et al: Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes. 52:588–595. 2003. View Article : Google Scholar : PubMed/NCBI

141 

Veenendaal LM, Kranenburg O, Smakman N, Klomp A, Borel Rinkes IH and van Diest PJ: Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases. Cell Oncol. 30:1–11. 2008.PubMed/NCBI

142 

Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, et al: Therapeutic antibody targeting of individual Notch receptors. Nature. 464:1052–1057. 2010. View Article : Google Scholar : PubMed/NCBI

143 

Kim JW, Shin MK and Kim BC: Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinoma. J Korean Med Sci. 30:16–23. 2015. View Article : Google Scholar : PubMed/NCBI

144 

Akiyoshi T, Nakamura M, Yanai K, Nagai S, Wada J, Koga K, Nakashima H, Sato N, Tanaka M and Katano M: Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology. 134:131–144. 2008. View Article : Google Scholar : PubMed/NCBI

145 

Aleksic T and Feller SM: Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells. Cell Commun Signal. 6:82008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Fu Y, Yuan SS, Zhang LJ, Ji ZL and Quan XJ: Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review). Oncol Lett 20: 2595-2605, 2020.
APA
Fu, Y., Yuan, S., Zhang, L., Ji, Z., & Quan, X. (2020). Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review). Oncology Letters, 20, 2595-2605. https://doi.org/10.3892/ol.2020.11833
MLA
Fu, Y., Yuan, S., Zhang, L., Ji, Z., Quan, X."Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review)". Oncology Letters 20.3 (2020): 2595-2605.
Chicago
Fu, Y., Yuan, S., Zhang, L., Ji, Z., Quan, X."Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review)". Oncology Letters 20, no. 3 (2020): 2595-2605. https://doi.org/10.3892/ol.2020.11833
Copy and paste a formatted citation
x
Spandidos Publications style
Fu Y, Yuan SS, Zhang LJ, Ji ZL and Quan XJ: Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review). Oncol Lett 20: 2595-2605, 2020.
APA
Fu, Y., Yuan, S., Zhang, L., Ji, Z., & Quan, X. (2020). Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review). Oncology Letters, 20, 2595-2605. https://doi.org/10.3892/ol.2020.11833
MLA
Fu, Y., Yuan, S., Zhang, L., Ji, Z., Quan, X."Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review)". Oncology Letters 20.3 (2020): 2595-2605.
Chicago
Fu, Y., Yuan, S., Zhang, L., Ji, Z., Quan, X."Atonal bHLH transcription factor 1 is an important factor for maintaining the balance of cell proliferation and differentiation in tumorigenesis (Review)". Oncology Letters 20, no. 3 (2020): 2595-2605. https://doi.org/10.3892/ol.2020.11833
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team